Chronic social stress during adolescence in mice alters fat distribution in late life: prevention by antidepressant treatment.
Obesity and visceral fat accumulation are key features of the metabolic syndrome that represents one of the main health problems in western societies due to its neurovascular and cardiovascular complications. Epidemiological studies have identified chronic stress exposure as an important risk factor for the development of obesity and metabolic syndrome, but also psychiatric diseases, especially affective disorders. However, it is still unclear if chronic stress has merely transient or potentially lasting effects on body composition. Here, we investigated the effects of chronic social stress during the adolescent period on body fat composition in mice one year after the cessation of the stressor. We found that stress exposure during the adolescent period decreases subcutaneous fat content, without change in visceral fat, and consequently increases the visceral fat/subcutaneous fat ratio in adulthood. Further, we demonstrated that treatment with a selective serotonin reuptake inhibitor (paroxetine) during stress exposure prevented later effects on body fat distribution. These results from a recently validated chronic stress paradigm in mice provide evidence that stressful experiences during adolescence can alter body fat distribution in adulthood, thereby possibly contributing to an increased risk for metabolic diseases. Antidepressant treatment disrupted this effect underlining the link between the stress hormone system, metabolic homeostasis and affective disorders.
Schmidt
M V
MV
Max Planck Institute of Psychiatry, Munich, Germany. mschmidt@mpipsykl.mpg.de
Czisch
M
M
Sterlemann
V
V
Reinel
C
C
Sämann
P
P
Müller
M B
MB
D050153:Abdominal Fat / Q000187:drug effects / Q000473:pathology*; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001522:Behavior, Animal / Q000187:drug effects; D001786:Blood Glucose / Q000187:drug effects; D003345:Corticosterone / Q000097:blood; D004435:Eating / Q000187:drug effects; D008297:Male; D051379:Mice; D023421:Models, Animal; D009043:Motor Activity / Q000187:drug effects; D017374:Paroxetine / Q000627:therapeutic use*; D012919:Social Behavior; D013315:Stress, Psychological / Q000188:drug therapy / Q000473:pathology*; D050151:Subcutaneous Fat / Q000187:drug effects / Q000473:pathology
D000928:Antidepressive Agents; D001786:Blood Glucose; D017374:Paroxetine; D003345:Corticosterone